Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Christian Angermayer · Said 1 Jul 2025 · angermayer-0107

Quote

Commitment (own venture)

“For the next 9 – 12 months, atai expects: Phase 2b readout for RL-007 (cognitive impairment associated with schizophrenia/CIAS), anticipated mid this year (via atai’s 51.9% stake in Recognify) Phase 2b open label extension and Phase 2a open label data for BPL-003 in Q3’2025 End-of-Phase 2b meeting request submitted with FDA for BPL-003 in Q3’25”
· atai Life Sciences – Strong Phase 2b topline data for BPL-003 (5-MeO-DMT) and further strategic backing · own post

'Upcoming Milestones' list, first three items (line breaks normalized).

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.

← Earlier · Later → · All statements